लोड हो रहा है...
Evaluating immune responses after sipuleucel-T therapy
Following FDA approval of sipuleucel-T in 2010 for metastatic castration resistant prostate cancer (mCRPC), several studies have described the effect of sipuleucel-T on peripheral immune responses. Retrospective associations have also been made with immune responses and survival. A recently publishe...
में बचाया:
| में प्रकाशित: | Cancer Biol Ther |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Taylor & Francis
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622939/ https://ncbi.nlm.nih.gov/pubmed/26054644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1056417 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|